54 results found.

Peripheral Vascular Diseases Clinical Trial using Stenting (Smart Stent); Stenting after PEB (Smart Stent, Invatec); Atherectomy (SilverHawk device)

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Randomized Trial of Stenting After Dilation With or Without Paclitaxel Eluting Balloon or Atherectomy in Patients With Symptomatic Peripheral Artery Disease.
Stenting (Smart Stent); Stenting after PEB (Smart Stent, Invatec); Atherectomy (SilverHawk device)

Ischemia, Phantom Limb Pain, Vascular Disease, or Chronic Pain Clinical Trial using Sciatic catheter; Stump catheter

University of British Columbia - Recruiting 16 years to 90 years.
- Ultrasound Guided Sciatic Perineural Catheter vs Surgically Placed Sciatic Stump Catheter for Below Knee Amputations: Is There A Difference in Patient Outcomes.
Sciatic catheter; Stump catheter

Critical Limb Ischemia, Peripheral Arterial Disease, or Periphera Clinical Trial using Bone marrow concentration device; Placebo procedure (sham)

Biomet, Inc. - Recruiting 21 years or older.
- MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD).
Bone marrow concentration device; Placebo procedure (sham)

Peripheral Artery Disease, or Peripheral Vascular Disease Clinical Trial using Astron/Pulsar-18 stent

Biotronik AG - Recruiting 18 years or older.
- BIOTRONIK - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe).
Astron/Pulsar-18 stent

Peripheral Artery Disease, or Peripheral Vascular Disease Clinical Trial using Astron/Pulsar Stents

Biotronik, Inc. - Recruiting 18 years or older.
- The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents.
Astron/Pulsar Stents

Caridovascular Disease, Congenital Heart Disease, or Pulmonary Hy Clinical Trial using Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

National Institutes of Health Clinical Center (CC) - Recruiting 21 years or older.
- Real-Time MRI Right Heart Catheterization Using Passive Catheters.
Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

Type 2 Diabetes Mellitus Clinical Trial using Ertugliflozin; Placebo

Merck Sharp & Dohme Corp. - Recruiting 40 years or older.
- Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (MK-8835/PF-04971729) in Subjects With Type 2 Diabetes Mellitus and Established Vascular Disease.
Ertugliflozin; Placebo

Atherosclerosis, or Coronary Artery Disease Clinical Trial

University Hospital Inselspital, Berne - Recruiting 18 years or older.
- Innate Human Collateral Supply to Different Vascular Regions.

Critical Limb Ischemia (CLI), or Peripheral Vascular Disease (PVD Clinical Trial using Magellanr

Arteriocyte, Inc. - Recruiting 18 years to 85 years.
- Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia.
Magellanr

Coronary Artery Disease Clinical Trial using Serelaxin; Placebo

Novartis - Recruiting 18 years or older.
- A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-controlled Study to Evaluate the Effects of Intravenous Serelaxin Infusion on Micro- and Macrovascular Function in Patients With Coronary Artery Disease.
Serelaxin; Placebo

Pulmonary Hypertension Clinical Trial

Chinese Pulmonary Vascular Disease Research Group - Recruiting 15 years to 65 years.
- the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension.

Coronary Artery Disease Clinical Trial using Vascular Access Device; Standard Manual Compression

Borgess Research Institute - Recruiting 18 years to 85 years.
- A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA (Device Name) 2 Access System Compared to Manual Compression.
Vascular Access Device; Standard Manual Compression

Retinal Vascular Disease Clinical Trial using Swept-Source Optical Coherence Tomography

Duke University - Recruiting 18 years or older.
- Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging.
Swept-Source Optical Coherence Tomography

Atrial Fibrillation, Hypertension, Diabetes, Chronic Heart Failur Clinical Trial using Medtronic Reveal XT implantable loop recorder

Medical University of Graz - Recruiting 18 years or older.
- Randomized Controlled Trial to Evaluate Implanted Event Recorders for the First Diagnosis of Atrial Fibrillation in High-risk Patients.
Medtronic Reveal XT implantable loop recorder

Peripheral Vascular Disease, Peripheral Artery Disease, Carotid S Clinical Trial

New York University School of Medicine - Recruiting 21 years or older.
- Platelet Activity in Vascular Surgery.

Idiopathic Parkinson's Disease Clinical Trial

University of Saskatchewan - Recruiting N/A or older.
- Vascular Abnormalities in Idiopathic Parkinson's Disease.

Peripheral Vascular Disease, or Hemorrhage Clinical Trial using EVICEL T Fibrin Sealant (Human)

Ethicon, Inc. - Recruiting 18 years or older.
- A Prospective, Single-Arm, Observational, Non-interventional Study for EVICEL T Fibrin Sealant (Human) When Used as an Adjunct to Haemostasis in Vascular Surgery.
EVICEL T Fibrin Sealant (Human)

Obstructive Coronary Artery Disease, or Coronary Artery Disease Clinical Trial using rosuvastatin

Mount Sinai School of Medicine - Recruiting 18 years or older.
- YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering.
rosuvastatin

Heart Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Diagnosis and Treatment of Patients With Heart and Vascular Disease (Training Protocol).

Chronic Kidney Disease Clinical Trial using The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access

TVA Medical Inc. - Recruiting 18 years or older.
- Novel Endovascular Access Trial (NEAT): A Study of the FLEX System for Percutaneous AV Fistula Creation in Hemodialysis Patients.
The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access

End-stage Renal Disease, or Kidney Failure, Chronic Clinical Trial using HAVG graft implantation

Humacyte, Inc. - Recruiting 18 years to 75 years.
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease.
HAVG graft implantation

Peripheral Arterial Disease, or Peripheral Vascular Disease Clinical Trial using HAVG graft implantation

Humacyte, Inc. - Recruiting 18 years to 80 years.
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease.
HAVG graft implantation

Vascular Disease Clinical Trial using ambrisentan

GlaxoSmithKline - Recruiting 18 years to 75 years.
- An Open Label Phase IIIb Study to Evaluate Efficacy and Safety of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH).
ambrisentan

Metabolic Acidosis, or Chronic Kidney Disease Clinical Trial using Sodium bicarbonate; Control

University of Colorado, Denver - Recruiting 40 years to 70 years.
- Effect of Treatment of Metabolic Acidosis on Vascular Function in Patients With Chronic Kidney Disease: A Pilot Study.
Sodium bicarbonate; Control

Carotid Stenosis Clinical Trial using Gadobutrol (Gadovist, BAY86-4875)

Bayer - Recruiting 18 years or older.
- Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels.
Gadobutrol (Gadovist, BAY86-4875)

Angioplasty, Cardiovascular Disease, Chronic Coronary Occlusion, Clinical Trial using XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Abbott Vascular - Recruiting 18 years or older.
- Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use..
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Pulmonary Hypertension Clinical Trial using 3-Helium gas

Sheffield Teaching Hospitals NHS Foundation Trust - Recruiting 18 years or older.
- Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease.
3-Helium gas

Cardiovascular Diseases, Coronary Artery Disease, Myocardial Isch Clinical Trial

Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. - Recruiting 18 years to 75 years.
- Postmarketing Surveillance Registry to Monitor Everolimus-eluting Bioresorbable Vascular Scaffold Following Rotational Atherectomy for the Treatment of Complex Coronary Lesions - The ASSURE ROT Registry.

Cardiovascular Disease Clinical Trial using Control; Peanut

Penn State University - Recruiting 20 years to 50 years.
- The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function.
Control; Peanut

Cardiovascular Disease, Myocardial Infarction, Thrombus, or Prima Clinical Trial using Bioresorbable vascular scaffold; Durable polymer everolimus-eluting metallic stent

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction.
Bioresorbable vascular scaffold; Durable polymer everolimus-eluting metallic stent

Coronary Artery Disease, Valvular Diseases, or Vascular Diseases Clinical Trial

University of California, Davis - Recruiting 18 years or older.
- Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery.

Aortic Aneurysm, Penetrating Ulcer, or Vascular Disease Clinical Trial using Zenithr TX2r Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)

Cook - Recruiting 18 years or older.
- Zenithr TX2r Low Profile TAA Endovascular Graft Clinical Study.
Zenithr TX2r Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)

Coronary Artery Disease Clinical Trial using Resolute Integrity Stent

Medtronic Vascular - Recruiting 18 years or older.
- Resolute Integrity US A Postapproval Study of the Medtronic ResoluteT Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm.
Resolute Integrity Stent

Atherosclerosis Clinical Trial using Crossover of R-alpha lipoic acid and placebo

Oregon State University - Recruiting 50 years to 70 years.
- The Role of R-alpha Lipoic Acid in Treatment of Atherosclerotic Vascular Disease.
Crossover of R-alpha lipoic acid and placebo

Atherosclerosis Clinical Trial using R-alpha lipoic acid; Placebo

Oregon State University - Recruiting 18 years to 60 years.
- The Role of R-alpha Lipoic Acid in Prevention of Atherosclerotic Vascular Disease.
R-alpha lipoic acid; Placebo

Coronary Artery Disease, Cerebral Vascular Disease, Peripheral Ar Clinical Trial

New York University School of Medicine - Recruiting 21 years or older.
- Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients.

Intermittent Claudication, or Peripheral Vascular Diseases Clinical Trial using Treadmill Exercise Training; Arm Ergometry Exercise Training; Usual Care

University of Minnesota - Clinical and Translational Science Institute - Recruiting 18 years to 90 years.
- Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking.
Treadmill Exercise Training; Arm Ergometry Exercise Training; Usual Care

Diabetes, or Peripheral Vascular Disease Clinical Trial using Magic FootT

Yaffa Golan, Ltd. - Recruiting 18 years or older.
- A Pilot Study to Assess the Use of the Magic Foot in the Improvement of Subjective and Objective Parameters in Subjects With Foot Symptoms as a Result of Diabetes or Peripheral Vascular Disease..
Magic FootT

Chronic Obstructive Pulmonary Disease Clinical Trial

Columbia University - Recruiting 50 years to 75 years.
- Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary (MESA-COPD).

Coronary Artery Disease Clinical Trial using Implantation of everolimus-eluting bioresorbable vascular scaffold stent; Implantation of everolimus-eluting stents; Implantation of biolimus-eluting stents

University of Freiburg - Recruiting 18 years to 70 years.
- Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents.
Implantation of everolimus-eluting bioresorbable vascular scaffold stent; Implantation of everolimus-eluting stents; Implantation of biolimus-eluting stents

Type 2 Diabetes, or Peripheral Vascular Disease Clinical Trial using Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital

University of British Columbia - Recruiting 30 years or older.
- Early Post-Operative Dysglycemia in Patients With and Without Diabetes Post-Infrainguinal Bypass Surgery and the Effectiveness of a Diabetes Action Team in the Management of Diabetes Post Infrainguinal Bypass Surgery on Glycemic Control, Length of Stay, and Infection Rates: A Pilot Study.
Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital

Sickle Cell Disease Clinical Trial

Children's Hospital Los Angeles - Recruiting 13 years or older.
- Iron-mediated Vascular Disease in Sickle Cell Disease..

Vascular Disease Clinical Trial using Smoking intervention.

Rigshospitalet, Denmark - Recruiting 20 years to 90 years.
- Tobacco's Impact on Postoperative Complications in Acute Vascular Surgery. A Randomized Clinical Trial.
Smoking intervention.

Periodontitis, or Vascular Disease Clinical Trial

University of Oslo - Recruiting N/A or older.
- Periodontal-, Cardiovascular- and Aneurysmal Diseases..

Oxygen Consumption, Aortic Aneurysm, or Peripheral Arterial Disea Clinical Trial

NHS Lothian - Recruiting N/A or older.
- Study of Post-operative Oxygen Consumption Following Vascular Surgery.

Cardiovascular Disease Risk, Vascular Function, or Hemostatic Fun Clinical Trial using 81 mg enteric coated aspirin

University of Illinois at Urbana-Champaign - Recruiting 40 years to 60 years.
- Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting.
81 mg enteric coated aspirin

Aortic Aneurysm, Abdominal, Aneurysm, Aortic Disease, Vascular Di Clinical Trial using Supervised exercise training; Usual care control

Sheffield Teaching Hospitals NHS Foundation Trust - Recruiting 50 years to 85 years.
- Exercise Therapy for Abdominal Aortic Aneurysm Disease: a Feasibility Study.
Supervised exercise training; Usual care control

Prevention, Screening, Abdominal Aortic Aneurysms, Peripheral Art Clinical Trial using Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Viborg Hospital - Recruiting 65 years to 74 years.
- Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark.
Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Coronary Artery Disease Clinical Trial using 6R-BH4

University of Oxford - Recruiting 18 years or older.
- A Randomised, Placebo-Controlled Study of Two Doses of Oral 6R-BH4 on Vascular Function in Subjects With Coronary Artery Disease.
6R-BH4

Coronary Artery Disease Clinical Trial using sirolimus drug eluting coronary stent CypherT (Cordis Corp, Johnson & Johnson Co); paclitaxel polymer drug eluting stent Taxus LibertŠT (Boston Scientific, Natick MS); zotarolimus drug eluting coronary stent EndeavorT (Medtronic, Santa Rosa, CA); LibertŠ bare metal coronary stent LibertŠT BMS(Boston Scientific, Natick, MS)

A.O. Ospedale Papa Giovanni XXIII - Recruiting 18 years or older.
- In-Vivo Vascular Response of Sirolimus-,Paclitaxel- and Zotarolimus-Eluting Stents in Long Lesions Requiring Overlapping. A Prospective, Randomized, Controlled Study Using Optical Coherence Tomography.
sirolimus drug eluting coronary stent CypherT (Cordis Corp, Johnson & Johnson Co); paclitaxel polymer drug eluting stent Taxus LibertŠT (Boston Scientific, Natick MS); zotarolimus drug eluting coronary stent EndeavorT (Medtronic, Santa Rosa, CA); LibertŠ bare metal coronary stent LibertŠT BMS(Boston Scientific, Natick, MS)

Chronic Kidney Disease, or Hypertension Clinical Trial using Procedure: Regional phenylephrine arterial infusion

University of Michigan - Recruiting 18 years to 55 years.
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide.
Procedure: Regional phenylephrine arterial infusion

Peripheral Vascular Disease Clinical Trial

University Health Network, Toronto - Recruiting 30 years or older.
- Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk.